NLS Collaboration

Swedish pre-clinical biomarker assay company Offspring Biosciences and US spatial biology and biomarker analytics company Flagship Biosciences have announced a strategic partnership. The partnership aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development, the companies state. “Together, Flagship Biosciences and Offspring Biosciences will provide a seamless […]

The company’s collaborative project with Vecura at Karolinska University Hospital and Uppsala University has been awarded SEK 850,000 from the Center for Advanced Medical Products (CAMP). The purpose of the project is to develop an automated production process of CAR T-cells (ELC-401) for use in clinical studies. The production process will be developed in a […]

Orion Corporation and Glykos Finland have entered into a research collaboration and licensing agreement to develop next-generation antibody-drug conjugates (ADCs). Under the agreement, Orion gains access to Glykos’ ADC technologies, initiating an ADC program with the potential for expansion into two additional programs in the future. Orion will be responsible for the target selection, research, […]

We would like to thank our readers, subscribers and collaboration partners for a fruitful 2023, and we wish you all a most wonderful holiday season! 2023 has been – yet another – challenging year, but we have also seen Nordic life science companies and researchers making great progress and announcing positive updates and results. Explore […]

The Novo Nordisk Foundation (NNF) is to establish a state-of-the-art research and vaccine development initiative in collaboration with the University of Copenhagen. Research at the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) will focus initially on TB, influenza and Group A Streptococcus (GAS), which collectively cause more than 2.5 million deaths per year. […]

Elekta has announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma. “We are thrilled to collaborate with Bristol Myers Squibb to potentially advance the use of digital health interventions, such as in the treatment of melanoma,” says Anish Patankar, SVP & Head of Business Line Software at […]